Public health experts are debating how to help the 1 million children in the Philippines who received a new vaccine against dengue that could, in rare cases, sicken rather than protect them

Quick Read

The agency ruled that Dengvaxia, can only be used in individuals aged 9 to 16 living in parts of the United States where the dengue virus is endemic. Furthermore, the vaccine can only be given to children and teens who have had one previous laboratory-confirmed case of dengue

Quick Read

Sanofi limited access to vaccine after deaths of children were reported in the Philippines

Quick Read